Author Contributions: Dr Bhatt had full access
to all of the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis.
Study concept and design: Bhatt, Roe, Li, Harrington,
Berger, Cannon, Pollack, Gibler.
Acquisition of data:Bhatt, Roe, Peterson, Cannon,
Cohen, Kleiman, Peacock, Pollack, Gibler.
Analysis and interpretation of data: Bhatt,
Roe, Peterson, Li, Chen, Harrington, Greenbaum, Berger, Cannon, Cohen, Gibson,
Saucedo, Hochman, Boden, Brindis, Peacock, Smith, Pollack, Gibler, Ohman.
Drafting of the manuscript: Bhatt, Roe, Li,
Critical revision of the manuscript for important
intellectual content: Bhatt, Roe, Peterson, Chen, Harrington, Greenbaum,
Berger, Cannon, Cohen, Gibson, Saucedo, Kleiman, Hochman, Boden, Brindis,
Peacock, Smith, Pollack, Gibler, Ohman.
Statistical analysis:Bhatt, Li, Chen, Cannon.
Obtained funding: Peterson, Harrington, Pollack,
Administrative, technical, or material support:
Roe, Harrington, Hochman, Boden, Peacock.
Study supervision: Roe, Peterson, Gibson, Ohman.
Executive Committee Oversight:Brindis.
Funding/Support: CRUSADE is funded by Millennium
Pharmaceuticals Inc and Schering Corporation. Bristol-Myers Squibb/Sanofi
Pharmaceuticals Partnership provides an unrestricted grant in support of the
program. Duke Clinical Research Institute owns the CRUSADE database and independently
manages data collection, data analysis, and data interpretation without sponsor
Role of the Sponsors:All manuscripts in CRUSADE
are prepared by independent authors who are not governed by the funding sponsors
and are reviewed by an academic publications committee before submission.
The funding sponsor has a representative (Theresa Palabrica, MD, Millennium
Pharmaceuticals Inc) on the committee who provides input into manuscript design
and content, but does not have authority to change any aspect of the manuscript.